This week Microsoft announced it will purchase the Rosetta Biosoftware division from Merck. This looks like a huge win/win/win combo; Merck gets out of a software business it doesn’t really “get”, Microsoft instantly becomes a serious player in the bioinformatics space with partnerships with Affymetrix and Illumina, and the biotech field gets serious software engineering for drug discovery and personal health.
I’ll be at Microsoft’s Connected Health Conference next week and will report back on what I learn there!
http://www.xconomy.com/seattle/2009/06/01/microsoft-dipping-toe-deeper-into-life-sciences-buys-rosetta-assets-from-merck/
Posted by: biotechbeachbum | June 4, 2009
Microsoft, Dipping Toe Deeper into Life Sciences, Buys Rosetta Assets from Merck | Xconomy
Posted in Uncategorized
